Maravai LifeSciences Holdings, Inc.
MRVI
$7.38
$0.081.10%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 68.64% | 87.53% | -37.74% | 73.67% | -304.44% |
| Total Depreciation and Amortization | -12.86% | -12.96% | 1.43% | 10.00% | 5.77% |
| Total Amortization of Deferred Charges | -- | -- | -38.75% | -47.08% | -- |
| Total Other Non-Cash Items | -69.32% | 3,283.87% | 163.69% | -111.01% | 122.11% |
| Change in Net Operating Assets | -181.09% | -206.10% | -86.07% | 109.44% | -81.49% |
| Cash from Operations | 138.89% | 192.28% | -55.54% | -215.33% | -158.88% |
| Capital Expenditure | 87.13% | 1.42% | 63.86% | 65.94% | 69.92% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -100.00% | 100.00% | -- |
| Cash from Investing | 88.57% | 80.82% | 57.13% | 67.34% | 47.65% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -17,758.82% | -3,676.47% | 99.66% | -2.63% | 9.81% |
| Issuance of Common Stock | -- | -- | 211.35% | -- | -- |
| Repurchase of Common Stock | -25.79% | -- | -- | -- | -16,753.57% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -103.61% | -9.21% | 27.85% | -389.61% | 157.65% |
| Cash from Financing | -6,352.41% | -1,027.06% | 99.23% | -1,119.65% | -772.81% |
| Foreign Exchange rate Adjustments | 115.32% | -58.90% | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -529.48% | -36.48% | 89.57% | -628.14% | -231.93% |